The study titled Double-blind, randomized, placebo-controlled crossover trial of alpha-lipoic acid for the treatment of fibromyalgia pain: the IMPALA trial, published in Pain (2021), investigated the efficacy of alpha-lipoic acid (ALA) in reducing pain among fibromyalgia patients. This randomized controlled trial found that ALA significantly reduced pain scores compared to
